Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide

Genetics in Medicine Open(2025)10.1016/j.gimo.2025.103463Source: DataRank Database

Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide is a research paper published in Genetics in Medicine Open (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

omim doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 0.00)OA: goldTopics (15)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

J. David Aponte ORCID,Cassidy Da Silva,Trevor Coward ORCID,Benedikt Hallgrímsson ORCID,Melita Irving ORCID

Live enrichment

PubMed:41340868 PMC:PMC12670446 OpenAlex:https://openalex.org/W4415216113

BioMarin Pharmaceutical

Grant: 111299

BioMarin Pharmaceutical

Grant: 684-692

BioMarin Pharmaceutical

Grant: 1070

BioMarin Pharmaceutical

Grant: 32891212

BioMarin Pharmaceutical

Grant: 10257

BioMarin Pharmaceutical

Grant: 10252

BioMarin Pharmaceutical

Grant: 2031541-5

BioMarin Pharmaceutical

Grant: 2032074-2

BioMarin Pharmaceutical

Grant: 2015-003836-11

Canadian Institutes of Health Research

Grant: 159920

Canada First Research Excellence Fund

Grant: REB15-1342

Canada First Research Excellence Fund

Grant: REB14-0340

Canada First Research Excellence Fund

Grant: 2022-00015

National Institute of Dental and Craniofacial Research

Grant: 1U01DE024440

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.gimo.2025.103463

publisherhttps://doi.org/10.1016/j.gimo.2025.103463

publisherhttps://api.elsevier.com/content/article/PII:S294977442501502X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S294977442501502X?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41340868

Fields of Study

Connective tissue disorders researchFibroblast Growth Factor ResearchProteoglycans and glycosaminoglycans researchMedicine0303 health sciences03 medical and health sciences

Keywords

AchondroplasiaCraniofacialMedical imagingMedical diagnosisCongenital diseasegeometric morphometricsFacial ImagingVosoritideArticle

Three-dimensional craniofacial imaging in children with achondroplasia treated with vosoritide

FAIR Checklist

Authors (6)

Funding (16 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)